Sample Type
Gender
Age Group
Blood
Male/Female
All Age Group
The two current FDA-approved 4th-generation HIV-1/2 combination antigen/antibody chemiluminescent, magnetic microparticle-based immunoassay (CMIA) and enzyme immunoassay (EIA) platform assays have significantly reduced the diagnostic seronegative window period but these assays are still insensitive to the three- to
best labs
Option Near Youlab comparison
As per your budgetAffordable
Price GuaranteedUNBIASED ADVICE
On LabsSUNDAY LAB
Labs available on Sundays